Commercial
Advanced Search
MPIssuedDate
  
MPNewsFlashTopicPub
MPPurposePub
MPNFSortOrder
  
MPPolicyPageName
  
Title
  
MPPageName
  
5/12/2023
Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated May 12, 2023)

The purpose of this communication is to provide notice regarding information and procedure codes related to testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence commercial members. Additionally, this Company document identifies when coverage is provided for clinical purposes, and the nonco​vered instances such as public health surveillance and screening. 




0.1Testing for SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) for Independence Commercial Members (Updated May 12, 2023)89689bbb-5b37-4282-b90a-69b3d315792d
5/12/2023
Coverage of the COVID-19 Vaccination for Independence Commercial Members (Updated on May 12, 2023)
This communication provides notice regarding information and procedure codes related to the coverage of SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) vaccines and administration of the vaccines​ that have been granted US Food and Drug Administration (FDA) approval and/or have received an Emergency Use Authorization (EUA). Coverage of SARS-CoV-2 (Coronavirus Disease 2019 (COVID-19)) vaccines granted an EUA shall remain in effect during the applicable EUA declaration, unless the specific EUA for a SARS-CoV-2 vaccine​ has been terminated and/or revoked. 


0.1Coverage of the COVID-19 Vaccination for Independence Commercial Members (Updated on May 12, 2023)233788d9-d742-40fd-82c7-fc63ba91963e
5/12/2023
Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial Members (Updated May 12, 2023)
The purpose of this document is to communicate the Company's coverage position for Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial members.  This communication addresses pharmaceutical prophylaxis and treatments of COVID-19 that have been granted FDA approval and/or have received an Emergency Use Authorization. Coverage for the pharmaceutical treatments granted an EUA shall remain in effect during the applicable EUA declaration, unless the specific EUA for a treatment have been terminated and revoked.escription plan when the member has a pharmacy benefit.

0.1Pharmaceutical Prophylaxis and Treatments of COVID-19 for Independence Commercial Members (Updated May 12, 2023)2d48a17a-b1f9-4a84-80b3-45d116483202
4/1/2023
4/01/2023 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Quarterly Code Update process. The procedure codes that represent these services will become effective on 04/01/2023, unless otherwise noted. For more information related to these services, please refer to specific policies when applicable.​​​​​​​​
04/01/2023 CPT & HCPCS Quarterly Code Update Coverage Determinations for Commercial Productsede56fec-5f22-4170-a5ef-244e16842de4
11/7/2022
Laboratory Testing, Vaccination, and Treatment for Monkeypox for Independence Commercial Members (Updated November 7, 2022)
The purpose of this document is to communicate the Company's coverage positions for laboratory testing, vaccination, and treatment for monkeypox.
0.1Laboratory Testing, Vaccination, and Treatment for Monkeypox for Independence Commercial Members (Updated November 7, 2022)b5760d4e-45de-4375-86b8-6216d6cd050c
1/4/2021
1/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Products
The intent of this document is to communicate Commercial Product coverage determinations for services identified through the Annual Code Update process. 
01/1/2021 CPT & HCPCS Annual Code Update Coverage Determinations for Commercial Productsb976b7b6-ff87-4f04-a559-d2f8805e0586
4/29/2020
Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)
The purpose of this News Article is to provide advance notice regarding direct supervision requirements for Incident to services performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in response to Coronavirus Disease 2019 (COVID-19).
1Direct Supervision Requirements for Incident to Services Performed by Certified Registered Nurse Practitioners (CRNPs) and Physician Assistants (PAs) in Response to COVID-19 (December 15, 2021)CC0B8A7BBD74419185258558007CCF61
Connect with Us

2023 Independence Blue Cross

Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.